Published Date: February 2023
Adult Clinical Oral Nutrition Market size is anticipated to exceed USD 13 billion by 2032, as per a new research report announced by Global Market Insights Inc.
Rapid globalization and increasing junk food consumption are among the prominent factors bolstering the demand for oral health nutrition therapy among adults. Based on a survey from the National Center for Health Statistics, in 2022, close to one-third of the U.S. adult population consumes junk foods on any given day. These factors are likely to increase the burden of malnourishment and other health issues due to poor diet. Junk foods are also key contributors to the high prevalence rate of non-communicable diseases, including obesity, boosting the need for oral nutrition support.
Adult clinical oral nutrition market from the fruit drinks product segment accounted over USD 1 billion in 2022, owing to high content of dietary fiber in fruit drinks, associated with lower incidence of obesity and cardiovascular diseases. Moreover, the rising production of juice-based oral nutritional supplements for the dietary management of malnourished patients will also strengthen the industry outlook.
Cancer segment held over 21% share of adult clinical oral nutrition market in 2022, due to rising prevalence of malnutrition among cancer patients. According to statistics from the British Association for Parenteral and Enteral Nutrition’s Malnutrition Advisory Action Group, malnutrition occurs in 40%-80% of cancer patients, leading to high risks of mortality and morbidity. Additionally, the mounting number of patients with gastrointestinal, lung, and other cancer types will drive expansion for adult oral nutritional therapy.
Browse key industry insights spread across 280 pages with 361 market data tables & 26 figures & charts from the report, “Adult Clinical Oral Nutrition Market Size By Product (Milk Based Products, Fruit Drinks, Desserts, Savory Products), By Therapeutic Area (Malnutrition, Dysphagia, Glycemia, Cancer, Gastrointestinal Disorders), By Form (Powder, Liquid), By Sales Channel (Brick and Mortar, Hospital Pharmacies, E-commerce), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/adult-clinical-oral-nutrition-market
Powder form segment registered 46% growth rate of the adult clinical oral nutrition market in 2022, attributed to rising awareness about protein powder as a critical source of nutrients among the younger populations, including millennials. Protein powder is known for its anti-cancer properties and can aid in lowering blood pressure. Furthermore, the increasing consumption of oral supplement powder for weight and chronic disease management will hasten the development of adult clinical oral nutrition therapy.
Adult clinical oral nutrition market revenue from the e-commerce sales channel segment to hit over USD 2 billion by 2032, given the convenience, reduced lead time, easy access, and availability of the products at reasonable price points. E-commerce distribution channels have also witnessed a significant upsurge during the lockdown phase of the COVID-19 pandemic. The strong demand for quality supplements in online stores will thus create growth opportunities for clinical oral supplement developers.
Asia Pacific adult clinical oral nutrition market exceeded more than USD 2 billion in 2022, on account of rising burden of malnutrition. With the rapid rise in the number of elderly people, the incidence of chronic diseases is expected to grow, in turn, augmenting the development for oral nutrition solutions. The emphasis on improving healthcare infrastructure will also add impetus to regional industry progression in the coming years.
Ajinomoto Cambrooke, Inc., Abbott Laboratories, Herbalife Nutrition, Perrigo Company, Victus, Inc. (Megalabs), Meiji Holdings, Co. Ltd., Danone, Fresenius Kabi AG, B Braun Melsungen AG, Medtrition, Cantabria Labs, Usana Health Sciences, Archer Daniels Midland Company, and Otsuka Pharmaceutical Co., Ltd. are among the prominent companies profiled in the market.
Rupali Swain, Subodh Kharad